FDA announced the first nine recipients of priority review vouchers, which offers expedited drug review to products aligned with national health priorities.

The Trump administration has struck a deal with EMD Serono to lower drug prices — part of a larger push from the administration to expand coverage and improve affordability for…

“It's been like living in a washing machine, it's been constant chaos,” former NIH official Jeremy Berg said at the #STATSummit

With HLTH 2025 just a few days away, we've already heard many of the biggest announcement timed to the event, headlined by significant funding rounds.

The FDA's rejections of Replimune and Capricor therapies show how instability threatens biotech innovation, CEOs say.

The American Medical Association president defended the physician group's restrained advocacy strategy toward the Trump administration

As far as Eli Lilly's Dan Skovronsky is concerned, the revolving door with the FDA — often a subject of criticism — can spin in a direction that is beneficial for society.

And other biotech news updates, brought to you by The Readout.

CEO Emma Walmsley said GSK has had a minimal role in an effort by the FDA to update the prescribing information of the long-shelved drug leucovorin

On this week’s episode of "The Readout LOUD," an interview with veteran biotech executive Clive Meanwell on the evolving obesity drug market and pricing policies in the U.S. and the…